Pharma channel feed – Endpoints News

Pharma channel feed

Updated: J&J’s third talc bankruptcy bid is stopped by Texas federal judge

2 months ago

Federal judge nixes FDA's lab-developed test rule, says it exceeded agency's authority

2 months ago

DC court sides with HHS in Vertex's fertility program fight

2 months ago

Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy

2 months ago

Lykos’ interim CEO is set to step down

2 months ago

Judge tosses Amgen's challenge to Colorado drug review board, says suit is 'too speculative'

2 months ago

J&J beats Viatris in patent fight over its antipsychotic drug, staving off competition

2 months ago

CHMP recommends seven label expansions and one new approval, rejects Lilly Alzheimer's drug

2 months ago

Milestone's shares dive after FDA again rejects drug for abnormal heart rhythm

2 months ago

European regulator rejects Lilly's Alzheimer’s drug over potentially fatal side effects

2 months ago

Novo inks second obesity deal of the week, with Lexicon oral drug partnership worth up to $1B

2 months ago

Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025

2 months ago

With tariffs on the way, generic drugmaking woes could hinder Trump’s reshoring plan

2 months ago

Kennedy announces 10,000 job cuts at HHS, with major reductions expected at FDA, NIH and CDC

2 months ago

Exelixis’ primary cancer drug wins FDA approval for neuroendocrine tumors

2 months ago

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

2 months ago

J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival

2 months ago

Trump tariffs would increase costs for almost every biopharma company, survey claims

2 months ago

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

2 months ago

Eisai cuts Leqembi 2027 sales forecast by half but expects 'continued growth'

2 months ago

Senate committee backs Dr. Oz's nomination to lead CMS

2 months ago

Axsome reports Phase 3 win for Sunosi in adults with ADHD, with a high-dose caveat

2 months ago

GSK scores FDA approval for antibiotic to treat uncomplicated UTIs

2 months ago

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

2 months ago

First page Previous page 8 9 101112 13 14 Next page Last page